Showing results (431-440 of 459) with videos related to

Sort By:
Pageof 46
BMJ Open|April 20, 2026
Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trialNatalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
The Journal of Antimicrobial Chemotherapy|January 21, 2014
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care unitsGloria Wong, Alexander Brinkman, Russell J Benefield, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patientsMaria E Riccio, Tess Verschuuren, Nadine Conzelmann, et al.
Infection Control and Hospital Epidemiology|March 26, 2026
Implementation of an adaptable semi-automated nonventilator hospital-acquired pneumonia (nvHAP) surveillance system in swiss acute care hospitals: a feasibility studyAline Wolfensberger, Mirjam Faes Hesse, Marc Hany, et al.
Antimicrobial Resistance and Infection Control|June 17, 2020
Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: results of a multicenter randomized placebo-controlled clinical trialTessa Mulder, Marjolein Kluytmans-van den Bergh, Bart Vlaminckx, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 27, 2016
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort studyAndrew J Stewardson, Arthur Allignol, Jan Beyersmann, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2024
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control studyHongyu Zhou, Niccolò Buetti, Salvador Pérez-Galera, et al.
Open Forum Infectious Diseases|July 15, 2022
PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States CohortsStephen P Bergin, Sara B Calvert, John Farley, et al.
Emerging Microbes & Infections|November 29, 2021
Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the NetherlandsReina S Sikkema, Tijs Tobias, Nadia Oreshkova, et al.
Pageof 46